Pharma Consult ApS: Financial statements 2024
CVR: 43801708
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Pharma Consult ApS (CVR 43801708) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,390,551 and a net result of DKK 462,291 compared with DKK 509,944 the year before. That is a decrease of 4.4% compared with the year before. Equity in the 2024 report amounted to DKK 1,012,234. The solvency ratio was 71.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,390,551
- Profit/Loss
- DKK 462,291
- Equity
- DKK 1,012,234
- Total Assets
- DKK 1,415,437
- Employees
- 1
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Pharma Consult ApS has published its annual report for 2023. Gross profit came to DKK 1,454,116, and the net result was DKK 509,944.
About Pharma Consult ApS
Pharma Consult ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2023. The company is registered under the industry Anden teknisk rådgivning. The management consists of Shahin Jolaini. The company is owned by Shahin Jolaini. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,148,461 and a net result of DKK 343,471 compared with DKK 462,291 the year before. Equity in the 2025 report amounted to DKK 1,355,705.